Development of PROTACs to address clinical limitations associated with BTK-targeted kinase inhibitors
{{output}}
Chronic lymphocytic leukemia is a common form of leukemia and is dependent on growth-promoting signaling via the B-cell receptor. The Bruton tyrosine kinase (BTK) is an important mediator of B-cell receptor signaling and the irreversible BTK inhibitor ibrutini... ...
